Upturn unsubscribed user
$1.14/ day, billed weekly
Cancel anytime
(Ad-Free, Unlimited access)​
NO CREDIT CARD REQUIRED
CLOV logo CLOV
Upturn stock rating
CLOV logo

Clover Health Investments Corp (CLOV)

Upturn stock rating
$3.76
Last Close (24-hour delay)
Profit since last BUY-1.31%
upturn advisory
Strong Buy
BUY since 2 days
  • BUY Advisory
  • SELL Advisory (Profit)​
  • SELL Advisory (Loss)​
  • Profit
  • Loss
  • Pass (Skip investing)
Upturn Stock info Stock price based on last close
*as per simulation
(see disclosures)
Time period over
  • ALL
  • YEAR
  • MONTH
  • WEEK

Upturn Advisory Summary

10/28/2025: CLOV (4-star) is a STRONG-BUY. BUY since 2 days. Simulated Profits (-1.31%). Updated daily EoD!

Upturn Star Rating

rating

Above Average Performance

These Stocks/ETFs, based on Upturn Advisory, frequently surpass the market, reflecting reliable and trustworthy advice.

Number of Analysts

rating

4 Analysts rated it

Very few follow this stock; limited insights, higher-risk early investing.

1 Year Target Price $3.37

1 Year Target Price $3.37

Analysts Price Target For last 52 week
$3.37 Target price
52w Low $2.12
Current$3.76
52w High $4.87

Analysis of Past Performance

Type Stock
Historic Profit 168.83%
Avg. Invested days 31
Today’s Advisory Strong Buy
Upturn Star Rating upturn star rating icon
Upturn Advisory Performance Upturn Advisory Performance 3.0
Stock Returns Performance Upturn Returns Performance 5.0
Upturn Profits based on simulation Profits based on simulation
Upturn Profits based on simulation Last Close 10/28/2025

Key Highlights

Company Size Small-Cap Stock
Market Capitalization 1.95B USD
Price to earnings Ratio -
1Y Target Price 3.37
Price to earnings Ratio -
1Y Target Price 3.37
Volume (30-day avg) 4
Beta 2.11
52 Weeks Range 2.12 - 4.87
Updated Date 10/27/2025
52 Weeks Range 2.12 - 4.87
Updated Date 10/27/2025
Dividends yield (FY) -
Basic EPS (TTM) -0.08

Analyzing Revenue: Products, Geography and Growth

Revenue by Products

Product revenue - Year on Year

Earnings Date

Report Date -
When -
Estimate -
Actual -

Profitability

Profit Margin -2.68%
Operating Margin (TTM) -2.21%

Management Effectiveness

Return on Assets (TTM) -4.26%
Return on Equity (TTM) -12.59%

Valuation

Trailing PE -
Forward PE 37.74
Enterprise Value 967270753
Price to Sales(TTM) 1.21
Enterprise Value 967270753
Price to Sales(TTM) 1.21
Enterprise Value to Revenue 0.6
Enterprise Value to EBITDA -0.65
Shares Outstanding 420139394
Shares Floating 400031421
Shares Outstanding 420139394
Shares Floating 400031421
Percent Insiders 3.63
Percent Institutions 35.19

ai summary icon Upturn AI SWOT

Clover Health Investments Corp

stock logo

Company Overview

overview logo History and Background

Clover Health Investments Corp. was founded in 2014 with the mission to improve health outcomes for seniors by leveraging technology. It became public through a SPAC merger in 2021. Initially focused on New Jersey, it has expanded geographically.

business area logo Core Business Areas

  • Medicare Advantage Plans: Provides Medicare Advantage plans to eligible beneficiaries, offering comprehensive coverage beyond traditional Medicare.
  • Clover Assistant: A software platform that aims to provide physicians with real-time data and insights to improve patient care and reduce costs.

leadership logo Leadership and Structure

The leadership team includes Andrew Toy as Chief Executive Officer. The organizational structure is designed to support its technology-driven healthcare delivery model.

Top Products and Market Share

overview logo Key Offerings

  • Medicare Advantage Plans: Clover Health offers various Medicare Advantage plans. The number of members enrolled are increasing. Competitors include UnitedHealth Group (UNH), Humana (HUM), and CVS Health (CVS) through Aetna.
  • Clover Assistant: Clover Assistant is a key differentiator, designed to enhance physician decision-making. Competitors include electronic health record (EHR) systems like Epic and Cerner, and other population health management tools.

Market Dynamics

industry overview logo Industry Overview

The healthcare industry, particularly Medicare Advantage, is experiencing growth driven by an aging population and increasing demand for comprehensive health coverage. The market is competitive and subject to regulatory changes.

Positioning

Clover Health is positioned as a technology-driven health insurer, aiming to differentiate itself through its Clover Assistant platform. Its success depends on its ability to improve health outcomes and manage costs effectively.

Total Addressable Market (TAM)

The TAM for Medicare Advantage is substantial, estimated to be hundreds of billions of dollars annually. Clover Health's position within this TAM is relatively small, but it has potential for growth if it can expand its geographic reach and attract more members.

Upturn SWOT Analysis

Strengths

  • Technology-driven approach
  • Clover Assistant platform
  • Focus on improving health outcomes
  • Data-driven decision-making

Weaknesses

  • Relatively small market share
  • History of unprofitability
  • High marketing and administrative costs
  • Dependence on government regulations

Opportunities

  • Expanding geographic reach
  • Increasing Medicare Advantage enrollment
  • Partnering with healthcare providers
  • Leveraging technology to improve efficiency

Threats

  • Increasing competition
  • Changes in government regulations
  • Rising healthcare costs
  • Adverse selection in Medicare Advantage plans

Competitors and Market Share

competitor logo Key Competitors

  • UNH
  • HUM
  • CVS

Competitive Landscape

Clover Health's competitive advantage lies in its technology platform. However, it faces significant competition from larger, more established players with greater financial resources and market share.

Growth Trajectory and Initiatives

Historical Growth: Historical growth has been driven by increased enrollment in its Medicare Advantage plans and expansion into new geographic markets.

Future Projections: Future growth projections are based on analyst estimates of continued enrollment growth and improved operational efficiency. Estimates vary considerably.

Recent Initiatives: Recent initiatives include expanding its Clover Assistant platform, partnering with more healthcare providers, and entering new geographic markets.

Summary

Clover Health is a technology-driven healthcare company striving to disrupt the Medicare Advantage market. Its Clover Assistant platform shows promise, but the company faces significant challenges, including achieving profitability and competing with larger players. Revenue growth is encouraging, however, substantial improvement is needed. Regulatory risks also pose a significant threat.

Peer Comparison

Sources and Disclaimers

Data Sources:

  • SEC Filings
  • Company Investor Relations
  • Market Research Reports
  • Analyst Estimates

Disclaimers:

The data and analysis provided are for informational purposes only and should not be considered investment advice. Market share data is approximate and based on publicly available information. Financial data is subject to change.

Upturn AI Summarization AI Summarization is directionally correct and might not be accurate.

Upturn AI Summarization Summarized information shown could be a few years old and not current.

Upturn AI Summarization Fundamental Rating based on AI could be based on old data.

Upturn AI Summarization AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.

About Clover Health Investments Corp

Exchange NASDAQ
Headquaters Wilmington, DE, United States
IPO Launch date 2001-01-02
Co-Founder, CEO & Director Mr. Andrew Toy
Sector Healthcare
Industry Healthcare Plans
Full time employees 570
Full time employees 570

Clover Health Investments, Corp. provides medicare advantage plans in the United States. The company offers preferred provider organization and health maintenance organization plans to medicare-eligible individuals. It operates Clover Assistant, a software platform to execute strategy by enabling physicians to detect, identify, and manage chronic diseases earlier than they otherwise could. The company is based in Wilmington, Delaware.